SAADI RYAN H. (Chief Executive Officer) sold 1.2% of their position (1.44M shares) of TEVOGEN BIO HOLDINGS INC. on the open market
Open‑market sale worth $1.77M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/9/2025ACC: 0001062993-25-011293
DirectorOfficer10% Owner· Chief Executive Officer
Since Feb 2024
-1.44M
Net shares
Net seller
$1.77M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.44M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.44M
Price / share
$1.23
Trade value
$1.77M
% of position
1.2%
6/9/2025
118.25M→116.81M
Total
Net shares
−1.44M
Net value
-$1.77M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/9/2025 | S · Sale | −1.44M | $1.23 | $1.77M | 1.2% | 118.25M | 116.81M |
| Total | −1.44M | -$1.77M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned193.92K
Total
193.92K indirect193.92K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 193.92K | Indirect |
| Total | 193.92K | 193.92K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported